DUPIXENT is indicated for the treatment of adult and pediatric patients aged 12 yearsand older, weighing at least 40 kg, with eosinophilic esophagitis (EoE).
Support can make all the difference. DUPIXENT MyWay® is a patient support program that can help enable access to DUPIXENT and offers financial assistance for eligible patients, one-on-one nursing support, and more.Learn how we can help
6+ MONTHS OF AGE
6+ YEARS OF AGE
Eosinophilic phenotype or
18+ YEARS OF AGE
12+ YEARS OF AGE
Weighing at least 40 kg
CRSwNP, chronic rhinosinusitis with nasal polyposis; OCS, oral corticosteroids.